Down Syndrome Market è segementato da tipo di malattia (Traslocazione Down Syndrome, Mosaic Down Syndrome, Trisomy 21), By End-use (Hospitals and Clinics, Home Healthcare ....
I principali attori che operano nel Down Syndrome Market includono AC Immune SA, Alzheon, Inc., Annovis Bio, Inc., ManRos Therapeutics, NeuroNascent, Inc., Natera, Next Biosciences, AtilaBiosystems, Demeditec Biosystems, Myriad Genetics, Abnova Corporation e Thermo Fisher Scientific.
Down Syndrome Market